tradingkey.logo
tradingkey.logo
Search

Pasithea Therapeutics Announces Initiation Of Phase 1/1B Study Of Pas-004 In Adult Nf1 Patients And Activation Of First Clinical Trial Site

ReutersMay 14, 2025 12:06 PM
facebooktwitterlinkedin
View all comments0
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Sign up for Tradingkey to unlock the full content

Free signup

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

KeyAI